Auditory brainstem response screening for hearing loss in high risk neonates

D R Watson1, R J McClelland, D A Adams

  • 1Department of Otorhinolaryngology, Queen's University, Belfast, UK.

Insights

Auditory Brainstem Response (ABR) screening effectively identifies hearing impairment in at-risk newborns. This method offers high accuracy and can detect hearing loss earlier, reducing average detection age by 7 months.

Area of Science:

  • Audiology
  • Neonatal Medicine
  • Public Health

Background:

  • Newborn hearing screening is crucial for early intervention.
  • Infants in Special Care Baby Units (SCBU) have a higher risk of hearing impairment.
  • Traditional screening methods may have limitations in detecting all types of hearing loss.

Purpose of the Study:

  • To evaluate the Auditory Brainstem Response (ABR) as a screening tool for hearing impairment in high-risk newborns.
  • To assess the sensitivity and specificity of ABR audiometry in a SCBU population.
  • To determine the potential impact of an ABR-based screening program on early detection and cost-effectiveness.

Main Methods:

  • A 7-year study involving 417 high-risk newborns in an SCBU.
  • Hearing screening using ABR audiometry at birth.
  • Analysis of screening results, including pass/fail rates and confirmation of hearing impairment.

Main Results:

  • 332 out of 417 infants passed the initial ABR screen at 30 dBnHL.
  • 32 infants failed the screen, with 9 confirmed sensorineural hearing impairments.
  • An increased incidence of persistent middle ear disease was observed in the failure group.

Conclusions:

  • ABR audiometry demonstrates excellent sensitivity and specificity for detecting significant hearing loss in at-risk newborns.
  • Implementing an ABR-based screening program can reduce the average age of permanent hearing loss detection by 7 months.
  • A targeted ABR screening procedure is a cost-effective approach for early identification of hearing impairment.

Related Concept Videos